ConductScience.org, home

Paper32028640

Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance.

Cruz A and 8 others. Antioxidants (Basel), 2020. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance. Papers, record 32028640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32028640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.87
iCite
Revised in PubMed
2020-09-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cruz AAdriana
2Mota PPedro
3Ramos CCristiano
4Pires RFRita F
5Mendes CCindy
6Silva JPJosé P
7Nunes SCSofia C
8Bonifácio VDBVasco D B
9Serpa JJacinta

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PTDC/MEC-ONC/29327/2017fundação ciência e tecnologiaPubMed
UID/Multi/04462fundação ciência e tecnologiaPubMed

Source PubMed

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126520442HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).Tumour Biol2016https://conductscience.org/library/papers/26520442PubMed
224767708Ovarian cancer.Lancet2014https://conductscience.org/library/papers/24767708PubMed
325967350POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50 Lowering Capacity.Macromol Biosci2015https://conductscience.org/library/papers/25967350PubMed
429949936Glutathione in Ovarian Cancer: A Double-Edged Sword.Int J Mol Sci2018https://conductscience.org/library/papers/29949936PubMed
529992403Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.Target Oncol2018https://conductscience.org/library/papers/29992403PubMed
631635026Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.Nutrients2019https://conductscience.org/library/papers/31635026PubMed
78097674Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.Cancer Res1993https://conductscience.org/library/papers/8097674PubMed
81348364High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1348364PubMed
929921232Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer.BMC Evol Biol2018https://conductscience.org/library/papers/29921232PubMed
1017991446Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma.Free Radic Biol Med2008https://conductscience.org/library/papers/17991446PubMed
1130546448Oxidative stress induced by carboplatin promotes apoptosis and inhibits migration of HN-3 cells.Oncol Lett2018https://conductscience.org/library/papers/30546448PubMed
128420689Mechanisms of drug resistance in ovarian cancer.Cancer1993https://conductscience.org/library/papers/8420689PubMed
1319061505Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.Breast Cancer Res2008https://conductscience.org/library/papers/19061505PubMed
1414576837Cisplatin: mode of cytotoxic action and molecular basis of resistance.Oncogene2003https://conductscience.org/library/papers/14576837PubMed
1520220146Structural basis for feedback and pharmacological inhibition of Saccharomyces cerevisiae glutamate cysteine ligase.J Biol Chem2010https://conductscience.org/library/papers/20220146PubMed
1622474030Involvement of intracellular glutathione in regulating isoline-induced cytotoxicity in human normal liver L-02 cells.Toxicol Ind Health2013https://conductscience.org/library/papers/22474030PubMed
1712217624Glutathione depletion and oxidative stress.Parkinsonism Relat Disord2002https://conductscience.org/library/papers/12217624PubMed
1822025878Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma.World J Gastroenterol2011https://conductscience.org/library/papers/22025878PubMed
1928008141Chemoresistance and targeted therapies in ovarian and endometrial cancers.Oncotarget2017https://conductscience.org/library/papers/28008141PubMed
2031461931l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations.Molecules2019https://conductscience.org/library/papers/31461931PubMed

See all 39 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42435186Lipid Remodeling and Metabolic Adaptation in Cancer Cell Membranes: A Platform for Membrane-Targeted Nanotherapy.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435186PubMed
41838426Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity.FEBS Open Bio2026https://conductscience.org/library/papers/41838426PubMed
41627590Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics.Discov Oncol2026https://conductscience.org/library/papers/41627590PubMed
41558606Metabolic vulnerabilities in ovarian cancer decoding the nexus between nutrient adaptation and therapy resistance.J Adv Res2026https://conductscience.org/library/papers/41558606PubMed
41497304Overview of dendrimers as promising drug delivery systems with insight into anticancer and anti-microbial applications.Int J Pharm X2025https://conductscience.org/library/papers/41497304PubMed
41376855Platinum-resistant ovarian cancer: From mechanisms to treatment strategies.Genes Dis2026https://conductscience.org/library/papers/41376855PubMed
40872553Chrysin: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Potential.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872553PubMed
40749079Machine learning combining external validation to explore the immunopathogenesis of diabetic foot ulcer and predict therapeutic drugs.PLoS One2025https://conductscience.org/library/papers/40749079PubMed
40289180Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM).Cancer Gene Ther2025https://conductscience.org/library/papers/40289180PubMed
40155504Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer.Discov Oncol2025https://conductscience.org/library/papers/40155504PubMed
39034325Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasites.Nat Commun2024https://conductscience.org/library/papers/39034325PubMed
38966382Maleimide functionalized polycaprolactone micelles for glutathione quenching and doxorubicin delivery.Chem Sci2024https://conductscience.org/library/papers/38966382PubMed
38853202Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis.Apoptosis2024https://conductscience.org/library/papers/38853202PubMed
38500284The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.Curr Pharm Des2024https://conductscience.org/library/papers/38500284PubMed
38247476H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.Antioxidants (Basel)2023https://conductscience.org/library/papers/38247476PubMed
37564206Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.Int J Biol Sci2023https://conductscience.org/library/papers/37564206PubMed
36259505Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.Drug Deliv2022https://conductscience.org/library/papers/36259505PubMed
35585292Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.Reprod Sci2023https://conductscience.org/library/papers/35585292PubMed
34984953Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles.Drug Deliv2022https://conductscience.org/library/papers/34984953PubMed
34924003Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1.Cell Biosci2021https://conductscience.org/library/papers/34924003PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
FOLR12348PubTator's text mininghttps://conductscience.org/library/genes/2348NCBI Gene
GCLC2729PubTator's text mininghttps://conductscience.org/library/genes/2729NCBI Gene
GCLM2730PubTator's text mininghttps://conductscience.org/library/genes/2730NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32028640

GET https://conductscience.org/api/papers/v1/32028640/references?page=2